MedTrace Logo

Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT

NCT01594814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2014-12-15

No results posted yet for this study

Summary

Atrioventricular nodal reciprocating tachycardia (AVNRT) and atrioventricular reciprocating tachycardia (AVRT) are two similar supraventricular re-entry tachycardias (SVT) emerging in relatively young age in patients without apparent structural heart disease or significant comorbidities. The treatment of choice in those patients is radiofrequency ablation (RFA).

The PPRA study is a prospective observational study developed to thoroughly analyze quality of life, utility and willingness-to-pay of Polish patients undergoing RF ablation of AVNRT or AVRT.

Based on collected data the investigators will prepare a profile of patient who will benefit most from radiofrequency ablation and who should be scheduled in first place for the ablation in case of problems with accessibility to this service.

What is more an analysis of medical and indirect costs of care will be performed.

Conditions

  • Tachycardia, Atrioventricular Nodal Reentry
  • Re-entrant Atrioventricular Tachycardia

Interventions

PROCEDURE

RFA

radiofrequency ablation of slow pathway or accesory pathway

Sponsors & Collaborators

  • National Institute of Cardiology, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Mariusz Pytkowski, MD, PhD · National Institute of Cardiology, Warsaw, Poland

  • Michal M Farkowski, MD · National Institute of Cardiology, Warsaw, Poland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01594814 on ClinicalTrials.gov